TVRD Tvardi Therapeutics, Inc.
Healthcare$3.44-3.64%ClosedMarket Cap: $32.3M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$3.00
Target (Median)
$3.00
Target Range
$3.00 - $3.00
Upside from current price: -12.8%
Rating Distribution
0 Strong Buy4 Buy3 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-20 | Barclays | downgrade | Underweight | Equal Weight |
| 2026-04-01 | Barclays | maintain | Equal Weight | Equal Weight |
| 2026-04-01 | BTIG | maintain | Buy | Buy |
| 2026-04-01 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-10-14 | Raymond James | downgrade | Market Perform | Outperform |
| 2025-10-13 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.19 | $0.00 | 4 |
| Sun Dec 31 | $-2.14 | $1.2M | 3 |
| Mon Dec 31 | $-2.73 | $11.6M | 1 |
| Tue Dec 31 | $-1.95 | $29.4M | 1 |